Skip to main content
Clinical Trials/CTRI/2023/08/056417
CTRI/2023/08/056417Not yet recruitingPhase 4

To study the effect of oral magnesium supplementation on Blood pressure and lipid profile in prehypertensive patients: A prospective randomised controlled study - NI

Government medical college, Patial0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Individuals not consuming any antihypertensive medicine.
  • 2.Individuals having systolic blood pressure of 120-139mmHg
  • and diastolic blood pressure of 80-89mmHg.
  • 3.Ability to meet follow up requirements for minimum of 12 weeks.
  • 4.Patients who are willing to get enrolled in study.

Exclusion Criteria

  • 1.Age should be less than 18 yrs and more than 60 yrs.
  • 2.Chronic disease â?? Chronic Kidney Disease, Diabetes Mellitis, Coronary Artery Disease and Acute Liver Disease.
  • 3.Using any supplementation (multivitamins, Herbals medicine) within 6 months.
  • 4.Patients with any acute illness affecting hemodynamics like sepsis, fever, acute febrile illness etc.
  • 5.History of malignancy.
  • 6.History drug and alcohol abuse.
  • 7.Secondary Hypertension.
  • 8.Pregnant and lactating women.
  • 9.Patient unable to attend follow up.
  • 10.Patient who is refusing for enrolment into study.

Investigators

Sponsor
Government medical college, Patial

Similar Trials